Five out of seven cancer types with impaired TGF-β signaling indeed demonstrate reduced risk of cancer in obese individuals compared to controls with normal body mass index (BMI): skin melanoma, prostate cancer, breast cancer (premenopausal) (81), skin squamous cell carcinoma (82), and testicular cancer (83, 84). Here, TGFB1 is linked to cancer.